Kansas City — Kansas City, Kansas

Kansas City is a clinical research site located in Kansas City, Kansas, United States 66160.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Kansas City has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Parkinson Disease, Amyloidosis; Systemic.

Sponsors: AbbVie, Attralus, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kansas City?

Kansas City has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kansas City conducted?

Kansas City has 2 clinical trials on record, with 1 currently active. Their work covers Parkinson Disease, Amyloidosis; Systemic.

Is Kansas City accredited by Crixeo Health?

Kansas City has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kansas City?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.